Home / Inspections / 740214

FDA Inspection 740214 — Avadel Legacy Pharmaceuticals LLC

Avadel Legacy Pharmaceuticals LLC — FEI 3008832322

The FDA completed an inspection of Avadel Legacy Pharmaceuticals LLC on August 18, 2011 in Chesterfield, MO. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
August 18, 2011
Fiscal Year
2011
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Chesterfield, MO (United States)

Facility

Other inspections at this facility

  • 1091059 (NAI Wed Apr 24 2019 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1068774 (NAI Thu Oct 11 2018 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1027967 (VAI Fri Oct 06 2017 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 946968 (VAI Wed Sep 23 2015 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 859453 (NAI Mon Dec 09 2013 00:00:00 GMT+0000 (Coordinated Universal Time))

Recent compliance actions

FDA data resources